Trials / Completed
CompletedNCT03184701
Monitoring of Symptoms and Cognitive Function Using Telehealth
Remote Monitoring of Symptoms and Cognitive Function Using Telehealth
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Albert Einstein Healthcare Network · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
End-Stage Liver Disease (ESLD) is one of the ten leading causes of death in US. It is marked by episodic acute exacerbations of the underlying liver disease which often leads to severe symptoms, poor quality of life, mental deterioration and repeated hospitalizations. The overall purpose of this project is to introduce a telehealth based intervention (involving remote monitoring of symptoms and cognitive function initiated at the time of discharge of ESLD patients. This will support enhanced clinical care and improve self-management in ESLD population. In addition, it will reduce healthcare utilization, improve medication adherence and overall health outcomes
Detailed description
This is a single arm study to assess the effectiveness of an experimental telehealth intervention within the treatment of ESLD, and compare it with a historic cohort. All inpatients with advanced liver disease and at least 1 complication will be eligible to participate. the study group receives the Telehealth intervention and will be given an ipad preloaded with the instruments used for symptom monitoring and cognitive function assessment during the hospital admission.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Telehealth | Patients will be given an ipad with preloaded app (secured questions assessing their symptoms and cognitive function in a systematic timely way). The responses will be delivered to the care providers instantly, which will trigger an algorithmic clinical approach. |
Timeline
- Start date
- 2016-04-30
- Primary completion
- 2018-08-30
- Completion
- 2018-08-30
- First posted
- 2017-06-14
- Last updated
- 2020-04-17
- Results posted
- 2020-04-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03184701. Inclusion in this directory is not an endorsement.